Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04620369 · ClinicalTrials.gov registry record · Phase 3
Rose Geranium in Sesame Oil Nasal Spray for the Improvement of Nasal Vestibulitis Symptoms in Cancer Patients Receiving Chemotherapy
A Phase 3 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 106
- Enrollment target
NCT04620369: Completed Phase 3 study, sponsored by Mayo Clinic.
NCT04620369 is a Phase 3 study that has completed, run by Mayo Clinic. The registered enrollment target is 106 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04620369, a Phase 3 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 106 participants
- Enrollment target
Study Summary
This phase III trial compares rose geranium in sesame oil nasal spray to isotonic nasal saline in improving symptoms of nasal vestibulitis in cancer patients receiving chemotherapy. Nasal (nose) symptoms (dryness, discomfort, bleeding, scabbing or sores) due to inflammation, termed nasal vestibulitis, is reported as a side effect of cancer-directed therapy. Rose geranium in sesame oil nasal spray may work better than isotonic nasal saline in improving symptoms of nasal vestibulitis.
Interventions
- OTHER Questionnaire Administration
- DRUG Placebo Administration
- DRUG Rose Geranium in Sesame Oil Nasal Spray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2020-11-13 |
| Est. Completion | 2022-12-15 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04620369
The ClinicalTrials.gov registry entry for NCT04620369 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT04620369 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04620369 about?
NCT04620369 is a clinical study titled "Rose Geranium in Sesame Oil Nasal Spray for the Improvement of Nasal Vestibulitis Symptoms in Cancer Patients Receiving Chemotherapy". This phase III trial compares rose geranium in sesame oil nasal spray to isotonic nasal saline in improving symptoms of nasal vestibulitis in cancer patients receiving chemotherapy. Nasal (nose) symptoms (dryness, discomfort, bleeding, scabbing or sores) due to inflammation, termed nasal vestibuliti...
What is the current status of trial NCT04620369?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 106 participants. The study started on 2020-11-13. Estimated completion is 2022-12-15.
What interventions are being tested in trial NCT04620369?
The interventions under investigation include: Questionnaire Administration (OTHER), Placebo Administration (DRUG), Rose Geranium in Sesame Oil Nasal Spray (DRUG).
Who is sponsoring clinical trial NCT04620369?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.